A new era in cancer therapies is at hand

CAR-T therapy revolutionized cancer treatment by converting immune cells into specialized weapons targeting cancer. Emily Whitehead's remarkable recovery from leukemia in 2012 inspired further development of CAR-T, though it faced challenges with toxicity and limited effectiveness against solid tumors. Newer therapies, including radiopharmaceuticals and gene-targeting drugs, are now being explored as safer alternatives in ongoing human trials, promising to address the limitations of CAR-T for more cancers.